Viventia’s cancer drug gets fast track status
The designation means that the FDA will provide input into product development plans and may accept portions of the marketing application prior to the completion of the final
The designation means that the FDA will provide input into product development plans and may accept portions of the marketing application prior to the completion of the final
A number of additional patients are in screening and the company will allow those patients to complete the process and be either randomized into the trial or disqualified,
While statins are used primarily to lower cholesterol levels, there is evidence that these drugs may also have beneficial effects on blood vessel function independent of cholesterol levels.
The company has been studying the peptides, in combination with the company’s patented Oxiplex gel as a delivery vehicle, for use in bone growth applications. The promising results
Previously, Oncaspar’s administration was limited to intramuscular administration, which involves injecting the drug directly into the muscle and is often painful to patients. Intravenous administration provides clinicians with
ACP-104 is currently being evaluated in three clinical trials, all of which are being conducted in patients with schizophrenia. The first clinical trial is a placebo-controlled, single ascending-dose
Insomnia can often affect the quality of life for older people leading many to rely on commonly used tranquilizers such as benzodiazepines, known to be highly addictive. The
Human stem cells offer tremendous hope for the development of revolutionary medical treatments for a variety of human health problems including damaged muscle tissue, bone injuries and nerve
Dr Fuller Torrey, president of the Stanley Medical Research Institute in Bethesda, has found that the parasite known as Toxoplasma gondii, often found in cat droppings, can produce
Remoxy is an investigational drug in late-stage clinical development by Pain Therapeutics for the treatment of moderate-to-severe chronic pain. Under the terms of the agreement, King will make